IL149995A0 - Depsipeptides and pharmaceutical compositions containing the same - Google Patents
Depsipeptides and pharmaceutical compositions containing the sameInfo
- Publication number
- IL149995A0 IL149995A0 IL14999500A IL14999500A IL149995A0 IL 149995 A0 IL149995 A0 IL 149995A0 IL 14999500 A IL14999500 A IL 14999500A IL 14999500 A IL14999500 A IL 14999500A IL 149995 A0 IL149995 A0 IL 149995A0
- Authority
- IL
- Israel
- Prior art keywords
- depsipeptides
- same
- pharmaceutical compositions
- compositions containing
- grant
- Prior art date
Links
- 108010002156 Depsipeptides Proteins 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- -1 FR901228 Chemical class 0.000 abstract 1
- 102000000588 Interleukin-2 Human genes 0.000 abstract 1
- 108010002350 Interleukin-2 Proteins 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 230000001363 autoimmune Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000039 congener Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 229960003444 immunosuppressant agent Drugs 0.000 abstract 1
- 239000003018 immunosuppressive agent Substances 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 210000004698 lymphocyte Anatomy 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 230000001629 suppression Effects 0.000 abstract 1
- 230000004083 survival effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16973199P | 1999-12-08 | 1999-12-08 | |
US19358200P | 2000-03-30 | 2000-03-30 | |
PCT/US2000/033169 WO2001042282A1 (fr) | 1999-12-08 | 2000-12-06 | Depsipeptide et ses congeneres destines a etre utilises en tant qu'immunodepresseurs |
Publications (1)
Publication Number | Publication Date |
---|---|
IL149995A0 true IL149995A0 (en) | 2002-12-01 |
Family
ID=26865325
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14999500A IL149995A0 (en) | 1999-12-08 | 2000-12-06 | Depsipeptides and pharmaceutical compositions containing the same |
IL149995A IL149995A (en) | 1999-12-08 | 2002-06-03 | Depsipeptides and pharmaceutical compositions containing the same |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL149995A IL149995A (en) | 1999-12-08 | 2002-06-03 | Depsipeptides and pharmaceutical compositions containing the same |
Country Status (16)
Country | Link |
---|---|
US (2) | US6403555B1 (fr) |
EP (3) | EP1246839B1 (fr) |
JP (4) | JP4824890B2 (fr) |
KR (1) | KR20020062956A (fr) |
CN (1) | CN1414971A (fr) |
AT (3) | ATE353663T1 (fr) |
AU (1) | AU762525B2 (fr) |
BR (1) | BR0016154A (fr) |
CA (1) | CA2393682C (fr) |
DE (3) | DE60044542D1 (fr) |
DK (1) | DK1438966T3 (fr) |
ES (3) | ES2347284T3 (fr) |
HK (2) | HK1049849B (fr) |
IL (2) | IL149995A0 (fr) |
PT (1) | PT1438966E (fr) |
WO (1) | WO2001042282A1 (fr) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6822267B1 (en) * | 1997-08-20 | 2004-11-23 | Advantest Corporation | Signal transmission circuit, CMOS semiconductor device, and circuit board |
US8119159B2 (en) | 1999-02-22 | 2012-02-21 | Merrion Research Iii Limited | Solid oral dosage form containing an enhancer |
US7658938B2 (en) | 1999-02-22 | 2010-02-09 | Merrion Reasearch III Limited | Solid oral dosage form containing an enhancer |
EP1313872A1 (fr) * | 2000-09-01 | 2003-05-28 | Fujisawa Pharmaceutical Co., Ltd. | Procede de preparation de fr901228 |
WO2002055017A2 (fr) * | 2000-11-21 | 2002-07-18 | Wake Forest University | Methode de traitement de maladies auto-immunes |
US6632553B2 (en) * | 2001-03-27 | 2003-10-14 | Mti Microfuel Cells, Inc. | Methods and apparatuses for managing effluent products in a fuel cell system |
PT1426054E (pt) | 2001-08-21 | 2011-12-06 | Astellas Pharma Inc | Utilização medicinal de inibidor da histona desacetilase e método de avaliação do seu efeito antitumoral |
US8163764B2 (en) * | 2002-04-26 | 2012-04-24 | Asan Laboratories Company (Cayman) Limited | Skincare methods |
US20060275370A1 (en) * | 2002-07-25 | 2006-12-07 | Yih-Lin Chung | Method and compositions for treatment of epithelial damage |
US8846039B2 (en) * | 2002-04-26 | 2014-09-30 | Asan Laboratories Company (Cayman), Limited | Method for ameliorating pruritus |
US8883148B2 (en) * | 2002-04-26 | 2014-11-11 | Asan Laboratories Company (Cayman), Limited | Prevention of joint destruction |
US6809118B2 (en) * | 2002-07-25 | 2004-10-26 | Yih-Lin Chung | Methods for therapy of radiation cutaneous syndrome |
US8946295B2 (en) * | 2002-07-25 | 2015-02-03 | Sunny Pharmtech Inc. | Histone hyperacetylating agents for promoting wound healing and preventing scar formation |
EP1547617B1 (fr) * | 2002-08-20 | 2010-04-28 | Astellas Pharma Inc. | Inhibiteur de degradation de la matrice extracellulaire du cartilage arthrodial |
US7154002B1 (en) | 2002-10-08 | 2006-12-26 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
US7250514B1 (en) | 2002-10-21 | 2007-07-31 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
US7381825B2 (en) | 2003-03-17 | 2008-06-03 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
CA2529840A1 (fr) * | 2003-06-27 | 2005-01-06 | Astellas Pharma Inc. | Agent therapeutique contre le sarcome des tissus mous |
US20090285783A1 (en) * | 2003-07-09 | 2009-11-19 | Henry Ford Health System | Methods and compositions for cancer therapy using a novel adenovirus |
ES2344899T3 (es) * | 2003-09-25 | 2010-09-09 | Astellas Pharma Inc. | Agente antitumoral que comprende un inhibidor de histona desacetilasa y un inhibidor de topoisomerasa ii. |
WO2005066151A2 (fr) * | 2003-12-19 | 2005-07-21 | Takeda San Diego, Inc. | Inhibiteurs d'histone desacetylase |
WO2005065681A1 (fr) * | 2003-12-19 | 2005-07-21 | Takeda San Diego, Inc. | Derives de n-hydroxy-3-(3-(1h-imidazol-2-yl)-phenyl)-acrylamide et composes associes en tant qu'inhibiteurs d'histone deacetylase pour le traitement du cancer |
US20050187148A1 (en) * | 2004-02-25 | 2005-08-25 | Yoshinori Naoe | Antitumor agent |
US7951780B2 (en) * | 2004-02-25 | 2011-05-31 | Astellas Pharma Inc. | Antitumor agent |
EP1812036A2 (fr) * | 2004-11-17 | 2007-08-01 | The University Of Chicago | Inhibiteurs de l'histone desacetylase et leurs methodes d'utilisation |
EP1824831A2 (fr) | 2004-12-16 | 2007-08-29 | Takeda San Diego, Inc. | Inhibiteurs d'histone desacetylase |
WO2006122319A2 (fr) | 2005-05-11 | 2006-11-16 | Takeda San Diego, Inc. | Inhibiteurs d'histone deacetylase |
GB0511266D0 (en) * | 2005-06-02 | 2005-07-13 | Trust | Chemical compounds |
US7732475B2 (en) | 2005-07-14 | 2010-06-08 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
CA2621560A1 (fr) * | 2005-09-07 | 2007-03-15 | Braincells, Inc. | Modulation de la neurogenese par inhibition de la hdac |
CA2630216A1 (fr) * | 2005-11-18 | 2007-05-31 | Gloucester Pharmaceuticals, Inc. | Derives de metabolites de l'inhibiteur de hdac fk228 |
JP2009525955A (ja) * | 2006-01-13 | 2009-07-16 | タケダ サン ディエゴ インコーポレイテッド | ヒストンデアセチラーゼ阻害剤 |
EP2007397B1 (fr) | 2006-04-07 | 2013-07-24 | Merrion Research III Limited | Forme pharmaceutique solide par voie orale contenant un activateur |
CA2650520A1 (fr) * | 2006-04-24 | 2008-01-31 | Gloucester Pharmaceuticals | Traitement de tumeurs exprimant ras |
US8957027B2 (en) | 2006-06-08 | 2015-02-17 | Celgene Corporation | Deacetylase inhibitor therapy |
WO2007146234A2 (fr) * | 2006-06-09 | 2007-12-21 | Merrion Research Ii Limited | Forme posologique solide à administrer par voie orale contenant un activateur |
US7883855B2 (en) | 2006-07-21 | 2011-02-08 | Abbott Laboratories | Immunosuppressant drug extraction reagent for immunoassays |
EP2063905B1 (fr) | 2006-09-18 | 2014-07-30 | Raptor Pharmaceutical Inc | Traitement des troubles hépatiques par l'administration de conjugués de protéine associée au récepteur (rap) |
AU2007323215B2 (en) * | 2006-11-22 | 2012-07-19 | Karus Therapeutics Limited | Depsipeptides and their therapeutic use |
GB0623388D0 (en) * | 2006-11-23 | 2007-01-03 | Univ Southampton | Chemical compounds |
BRPI0720734A2 (pt) * | 2006-12-29 | 2014-01-07 | Gloucester Pharmaceuticals Inc | Preparação da romidepsina |
JP2010514801A (ja) * | 2006-12-29 | 2010-05-06 | グラスター ファーマシューティカルズ, インコーポレイテッド | ロミデプシンの精製 |
US7914999B2 (en) | 2006-12-29 | 2011-03-29 | Abbott Laboratories | Non-denaturing lysis reagent |
WO2008151306A1 (fr) * | 2007-06-05 | 2008-12-11 | Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University | Synthèse de composés cyclodepsipeptide ayant une activité antinéoplasique et/ou antimicrobienne |
GB0715750D0 (en) * | 2007-08-13 | 2007-09-19 | Karus Therapeutics Ltd | Chemical compounds |
ES2559311T3 (es) * | 2007-12-19 | 2016-02-11 | Abbott Laboratories | Reactivo de extracción de fármacos inmunosupresores para inmunoanálisis |
TW200950799A (en) | 2008-05-07 | 2009-12-16 | Merrion Res Iii Ltd | Compositions of GnRH related compounds and processes of preparation |
EP2293845A1 (fr) * | 2008-05-22 | 2011-03-16 | Karus Therapeutics Limited | Depsipeptides et leur utilisation thérapeutique |
DK2293846T3 (da) * | 2008-05-22 | 2013-10-14 | Karus Therapeutics Ltd | Depsipeptider og deres terapeutiske anvendelse |
CA2763299C (fr) * | 2009-06-26 | 2015-11-24 | Asan Laboratories Co., Ltd. | Methode traitement ou d'amelioration de toxicites mucocutanees ou oculaires |
TWI412359B (zh) * | 2009-07-07 | 2013-10-21 | Asan Lab Co Ltd | 組織蛋白去乙醯酵素抑制劑在製備治療或減緩黏膜/皮膚或眼睛毒性或副作用之藥物的用途 |
WO2011120033A1 (fr) | 2010-03-26 | 2011-09-29 | Merrion Research Iii Limited | Compositions pharmaceutiques d'inhibiteurs de facteur xa sélectifs destinées à une administration orale |
CA2804795A1 (fr) | 2010-07-12 | 2012-01-19 | Nicholas Vrolijk | Formes solides de la romidepsine et leurs utilisations |
US8859502B2 (en) | 2010-09-13 | 2014-10-14 | Celgene Corporation | Therapy for MLL-rearranged leukemia |
US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
CA2819234A1 (fr) | 2011-01-07 | 2012-07-12 | Merrion Research Iii Limited | Compositions pharmaceutiques de fer pour administration orale |
WO2013047509A1 (fr) * | 2011-09-30 | 2013-04-04 | 国立大学法人東北大学 | Nouvel inhibiteur de phosphatidylinositol-3-kinase et composition pharmaceutique |
AU2013203395A1 (en) | 2012-03-30 | 2013-10-17 | Isis Pharmaceuticals, Inc. | Compositions and methods for modulating TAU expression for reducing seizure and modifying a neurodegenerative syndrome |
AU2013202506B2 (en) | 2012-09-07 | 2015-06-18 | Celgene Corporation | Resistance biomarkers for hdac inhibitors |
AU2013202507B9 (en) | 2012-11-14 | 2015-08-13 | Celgene Corporation | Inhibition of drug resistant cancer cells |
TW202246503A (zh) * | 2013-07-19 | 2022-12-01 | 美商百健Ma公司 | 用於調節τ蛋白表現之組合物 |
NZ630311A (en) | 2013-12-27 | 2016-03-31 | Celgene Corp | Romidepsin formulations and uses thereof |
KR20150140177A (ko) * | 2014-06-05 | 2015-12-15 | 한미약품 주식회사 | 단백질 및 펩타이드의 면역원성을 감소시키는 방법 |
WO2016120378A1 (fr) | 2015-01-29 | 2016-08-04 | Novo Nordisk A/S | Comprimés contenant un agoniste de glp-1 et revêtement gastro-résistant |
CN110760564A (zh) * | 2019-10-16 | 2020-02-07 | 菲诺克生物科技(上海)有限公司 | 细胞周期检测方法及其所用试剂与试剂盒 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4268516A (en) | 1978-10-11 | 1981-05-19 | Pfizer Inc. | [1]Benzothiopyrano[4,3-c]pyrazoles as immunoregulatory agents |
US4950649A (en) * | 1980-09-12 | 1990-08-21 | University Of Illinois | Didemnins and nordidemnins |
GB8817743D0 (en) * | 1988-07-26 | 1988-09-01 | Fujisawa Pharmaceutical Co | Fr901228 substance & preparation thereof |
WO1993019778A1 (fr) | 1992-04-07 | 1993-10-14 | The Scripps Research Institute | Procede servant a provoquer la tolerance a un antigene au moyen de butyrate |
ZA946765B (en) | 1993-09-02 | 1996-02-15 | Dartmouth College | Methods of prolonged suppression of humoral immunity |
US5591717A (en) | 1994-04-06 | 1997-01-07 | Rojko; Jennifer L. | Branched apogenic peptide for inducing apoptosis |
WO1995033823A1 (fr) | 1994-06-03 | 1995-12-14 | The United States Of America, Represented By The Secretary Of The Navy | Procedes de stimulation selective de la proliferation des cellules t |
US5843943A (en) | 1994-12-29 | 1998-12-01 | The Regents Of The University Of California | Compounds for inhibition of ceramide-mediated signal transduction |
US5962019A (en) | 1995-08-25 | 1999-10-05 | Sangstat Medical Corporation | Oral cyclosporin formulations |
US5891653A (en) | 1995-12-29 | 1999-04-06 | Attfield; Derrick Cecil | Method of suppressing graft rejection by means of stress proteins |
US6777217B1 (en) | 1996-03-26 | 2004-08-17 | President And Fellows Of Harvard College | Histone deacetylases, and uses related thereto |
WO1998039412A1 (fr) | 1997-03-03 | 1998-09-11 | Duke University | Immunodepression |
DE19713626A1 (de) * | 1997-04-02 | 1998-10-08 | Bayer Ag | Neue Thiodepsipeptide zur Bekämpfung von Endoparasiten und ein einfaches Verfahren zu ihrer Herstellung |
WO1998046640A2 (fr) | 1997-04-15 | 1998-10-22 | Coulter International Corp. | Procedes et compositions permettant d'induire l'immunosuppression |
JP3494624B2 (ja) | 1997-09-02 | 2004-02-09 | 住友製薬株式会社 | 新規な環状テトラペプチド誘導体とその医薬用途 |
AU9395998A (en) | 1997-09-17 | 1999-04-05 | Genentech Inc. | Compositions and methods for the treatment of immune related diseases |
WO1999015174A1 (fr) | 1997-09-22 | 1999-04-01 | Sloan-Kettering Institute For Cancer Research | Composes de prenyle inverse utiles comme immunodepresseurs |
AU1399199A (en) | 1997-11-14 | 1999-06-07 | Merck & Co., Inc. | Immunosuppressant tetracyclic triterpenes |
AU1864999A (en) | 1997-12-15 | 1999-07-05 | Universite Laval | Methods and compositions for improving the success of cell transplantation in a host |
JPH11180873A (ja) | 1997-12-22 | 1999-07-06 | Kaken Shoyaku Kk | NF−κB活性阻害剤 |
US6211145B1 (en) * | 1997-12-25 | 2001-04-03 | Nisshin Flour Milling Co., Ltd. | Bicyclic depsipeptides |
US6001815A (en) * | 1997-12-25 | 1999-12-14 | Nisshin Flour Milling Co., Ltd. | Depsipeptides containing N-substituted glycine residue |
EP0931792B1 (fr) * | 1998-01-27 | 2004-01-07 | Nisshin Seifun Group Inc. | Depsipeptides comportant des acides aminés non naturelles |
US6287843B1 (en) | 1998-04-03 | 2001-09-11 | Pioneer Hi-Bred International, Inc. | Maize histone deacetylases and their use |
ATE331730T1 (de) * | 1999-01-13 | 2006-07-15 | Astellas Pharma Inc | Neue depsipeptid-verbindung |
-
2000
- 2000-12-06 AT AT04007814T patent/ATE353663T1/de not_active IP Right Cessation
- 2000-12-06 CN CN00817856A patent/CN1414971A/zh active Pending
- 2000-12-06 JP JP2001543579A patent/JP4824890B2/ja not_active Expired - Fee Related
- 2000-12-06 US US09/732,183 patent/US6403555B1/en not_active Expired - Lifetime
- 2000-12-06 DE DE60044542T patent/DE60044542D1/de not_active Expired - Lifetime
- 2000-12-06 DE DE60033453T patent/DE60033453T2/de not_active Expired - Lifetime
- 2000-12-06 IL IL14999500A patent/IL149995A0/xx unknown
- 2000-12-06 DE DE60011678T patent/DE60011678T2/de not_active Expired - Lifetime
- 2000-12-06 ES ES07002930T patent/ES2347284T3/es not_active Expired - Lifetime
- 2000-12-06 EP EP00983997A patent/EP1246839B1/fr not_active Revoked
- 2000-12-06 BR BR0016154-3A patent/BR0016154A/pt not_active Application Discontinuation
- 2000-12-06 AT AT07002930T patent/ATE470447T1/de not_active IP Right Cessation
- 2000-12-06 AT AT00983997T patent/ATE269354T1/de not_active IP Right Cessation
- 2000-12-06 DK DK04007814T patent/DK1438966T3/da active
- 2000-12-06 CA CA2393682A patent/CA2393682C/fr not_active Expired - Fee Related
- 2000-12-06 KR KR1020027007258A patent/KR20020062956A/ko not_active Application Discontinuation
- 2000-12-06 EP EP07002930A patent/EP1779859B1/fr not_active Expired - Lifetime
- 2000-12-06 AU AU20680/01A patent/AU762525B2/en not_active Ceased
- 2000-12-06 WO PCT/US2000/033169 patent/WO2001042282A1/fr active IP Right Grant
- 2000-12-06 ES ES04007814T patent/ES2282751T3/es not_active Expired - Lifetime
- 2000-12-06 ES ES00983997T patent/ES2225282T3/es not_active Expired - Lifetime
- 2000-12-06 EP EP04007814A patent/EP1438966B1/fr not_active Expired - Lifetime
- 2000-12-06 PT PT04007814T patent/PT1438966E/pt unknown
-
2002
- 2002-04-02 US US10/115,576 patent/US6548479B1/en not_active Expired - Lifetime
- 2002-06-03 IL IL149995A patent/IL149995A/en not_active IP Right Cessation
-
2003
- 2003-03-18 HK HK03101982.5A patent/HK1049849B/zh not_active IP Right Cessation
-
2005
- 2005-01-21 HK HK05100599A patent/HK1070268A1/xx not_active IP Right Cessation
-
2011
- 2011-01-28 JP JP2011017260A patent/JP2011084585A/ja not_active Withdrawn
-
2013
- 2013-03-06 JP JP2013043969A patent/JP2013107902A/ja not_active Withdrawn
-
2014
- 2014-07-31 JP JP2014155914A patent/JP2014205714A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL149995A (en) | Depsipeptides and pharmaceutical compositions containing the same | |
UA49869C2 (uk) | Нафтил-заміщені похідні бензимідазолу, фармацевтична композиція, спосіб лікування (варіанти) та спосіб інгібування людського фактора | |
IL245146A0 (en) | Phosphatidyl-inositol 3-kinase delta inhibitors | |
MXPA04004966A (es) | Nucleosidos de 3-beta-d-ribofuranoziltiazol(4,5-d(pirimidina y uso de los mismos. | |
WO2004031129A3 (fr) | Nouveaux composes destines au traitement des maladies auto-immunes, des maladies immuno-allergiques et des rejets en cas de greffes d'organes ou de tissus | |
HUP9800115A1 (hu) | Rifaximin alkalmazása kriptosporidiózis következtében fellépő hasmenés kezelésére használható gyógyszerkészítmények előállítására | |
UA35567C2 (uk) | Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату | |
DE60231522D1 (de) | Behandlung und vorbeugung von insulin-produzierende zelltransplantatabstossung | |
BG104091A (en) | Cd154 blockade therapty in tissue transplantation of pancreatic isles | |
ES2160643T3 (es) | Composiciones que contienen g-csf y proteina de union al tnf. | |
AU8216691A (en) | Autobiotics and their use in eliminating nonself cells in vivo | |
SG162614A1 (en) | Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors | |
NZ330944A (en) | Peptide derivatives | |
MXPA06014182A (es) | Nucleosidos de 3-??-d-ribofuranosiltiazolo[4,5-d]piridimina y usos de los mismos. | |
BG106548A (en) | Synergistic combinations of an nk1 receptor antagonist and a gaba structural analog | |
AU2002314056A1 (en) | Use of a vitamin d3 analogue for the treatment of autoimmune diabetes | |
HUP0000110A2 (hu) | Azaciklusos, azabiciklusos vagy tetrahidropiridinszármazékokat tartalmazó, fájdalom kezelésére alkalmas gyógyászati készítmények | |
HK1045456B (zh) | 病毒炎性調節蛋白在阻斷異種移植排斥中的治療新用途 | |
EP1939203A3 (fr) | Inhibiteurs de delta-isoforme de phosphatidyl-inositol-3-kinase humaine | |
LT2002105A (en) | Novel use of siberian fir oil | |
MX9801091A (es) | Uso combinado de interleukina-10 y ciclosporina para terapia de inmunosupresion. | |
TW200519078A (en) | 2-alkylidene-19-nor-vitamin d derivatives for the treatment of a second hip fracture |